13F-HR filed by STEMPOINT CAPITAL LP
STEMPOINT CAPITAL LP filed this 13F-HR for the quarter ended 2026-06-30, filed 2026-08-14, with 84 holding rows worth $580,521,914.
- Accession
- 0001420506-26-001687
- Filer
- CIK 1952142
- Filed
- 2026-08-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2026
A holdings report, 85 entries on the cover page, a total value of $580,521,914 stated on the cover page (in dollars after the unit check, H1), rows summing to $580,521,914 with VALUE read as dollars as filed, 13F file number 028-23724. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| TANGO THERAPEUTICS INC | 87583X109 | COM | 1,223,019 | $38,231,574 | dollars as filed | |
| ABIVAX SA- | 00370M103 | SPONSORED ADS | 283,657 | $37,800,132 | dollars as filed | |
| REVOLUTION MEDICINES INC COM | 76155X100 | Stock | 159,943 | $29,954,125 | dollars as filed | |
| ERASCA INC COM | 29479A108 | Stock | 1,565,913 | $28,687,526 | dollars as filed | |
| TYRA BIOSCIENCES INC | 90240B106 | COMMON STOCK | 632,754 | $20,210,163 | dollars as filed | |
| DIANTHUS THERAPEUTICS INC | 252828108 | COM | 200,851 | $19,578,955 | dollars as filed | |
| ENLIVEN THERAPEUTICS INC COM | 29337E102 | Stock | 346,914 | $17,605,886 | dollars as filed | |
| MINERALYS THERAPEUTICS INC | 603170101 | COM | 602,686 | $16,260,468 | dollars as filed | |
| BIOHAVEN LTD | G1110E107 | COM | 1,064,200 | $15,835,296 | dollars as filed | |
| SURROZEN INC | 86889P208 | COMMON STOCK | 602,798 | $13,786,568 | dollars as filed | |
| KINIKSA PHARMACEUTICALS INTL P ORD SHS CL A | G52694109 | Stock | 209,234 | $13,380,514 | dollars as filed | |
| SCHOLAR ROCK HLDG CORP | 80706P103 | COM | 239,146 | $13,153,030 | dollars as filed | |
| ALKERMES PLC | G01767105 | SHS | 248,015 | $12,994,746 | dollars as filed | |
| FIRST TRACKS BIOTHERAPEUTICS | 337185102 | ORD SHS *A* | 622,723 | $12,529,187 | dollars as filed | |
| PRAXIS PRECISION MEDICINES I | 74006W207 | COM NEW | 37,243 | $12,468,584 | dollars as filed | |
| ROIVANT SCIENCES LTD | G76279101 | SHS | 348,408 | $12,330,159 | dollars as filed | |
| BIOAGE LABS INC COM | 09077V100 | Stock | 464,171 | $11,376,831 | dollars as filed | |
| CG ONCOLOGY INC | 156944100 | COMMON STOCK | 159,349 | $11,321,746 | dollars as filed | |
| ORUKA THERAPEUTICS INC COM | 687604108 | Stock | 116,461 | $11,083,593 | dollars as filed | |
| IMMUNOVANT INC | 45258J102 | COM | 276,527 | $10,654,585 | dollars as filed | |
| CELCUITY INC | 15102K100 | COM | 98,203 | $10,273,998 | dollars as filed | |
| RELMADA THERAPEUTICS INC | 75955J402 | COMMON STOCK | 1,460,093 | $10,103,844 | dollars as filed | |
| CLIMB BIO INC | 28658R106 | COMMON STOCK | 742,745 | $9,685,395 | dollars as filed | |
| SPYRE THERAPEUTICS INC | 00773J202 | COM NEW | 106,926 | $9,492,890 | dollars as filed | |
| ZURA BIO LTD | G9TY5A101 | COMMON STOCK | 1,368,215 | $8,072,469 | dollars as filed | |
| Inflarx Nv | N44821101 | COM | 3,228,255 | $7,231,291 | dollars as filed | |
| AMYLYX PHARMACEUTICALS INC | 03237H101 | COM | 384,304 | $6,902,100 | dollars as filed | |
| CELLDEX THERAPEUTICS INC NEW | 15117B202 | COM NEW | 178,412 | $6,638,711 | dollars as filed | |
| OVID THERAPEUTICS INC | 690469101 | COMMON STOCK | 2,417,283 | $6,502,491 | dollars as filed | |
| EQUILLIUM INC | 29446K106 | COM | 2,016,607 | $6,453,142 | dollars as filed | |
| DEFINIUM THERAPEUTICS INC | 24477V105 | COM SHS | 137,124 | $6,450,313 | dollars as filed | |
| CYTOKINETICS INC | 23282W605 | COM NEW | 75,603 | $6,440,620 | dollars as filed | |
| DAMORA THERAPEUTICS INC | 36322Q206 | COMMON STOCK | 216,194 | $5,623,206 | dollars as filed | |
| INVENTIVA SA | 46124U107 | ADS | 1,426,320 | $5,391,490 | dollars as filed | |
| CENTURY THERAPEUTICS INC | 15673T100 | COM | 2,146,182 | $5,258,146 | dollars as filed | |
| AURA BIOSCIENCES INC | 05153U107 | COMMON STOCK | 714,280 | $5,071,388 | dollars as filed | |
| EYEPOINT INC COM NEW | 30233G209 | Stock | 338,471 | $4,840,135 | dollars as filed | |
| ASSEMBLY BIOSCIENCES INC | 045396207 | COMMON STOCK | 170,378 | $4,681,987 | dollars as filed | |
| WHITEHAWK THERAPEUTICS INC | 00032Q104 | CMN | 1,021,037 | $4,676,349 | dollars as filed | |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 76,075 | $4,591,887 | dollars as filed | |
| UNIQURE NV | N90064101 | SHS | 88,115 | $4,058,577 | dollars as filed | |
| COMPASS PATHWAYS PLC | 20451W101 | SPONSORED ADS | 284,769 | $4,029,481 | dollars as filed | |
| AVALYN PHARMA INC | 05348Y105 | COMMON STOCK | 118,000 | $3,884,560 | dollars as filed | |
| MAPLIGHT THERAPEUTICS INC | 56565P103 | COMMON STOCK | 106,906 | $3,831,511 | dollars as filed | |
| ALUMIS INC | 022307102 | COM | 135,736 | $3,819,611 | dollars as filed | |
| AXSOME THERAPEUTICS INC. COM | 05464T104 | Stock | 15,375 | $3,763,339 | dollars as filed | |
| MONTE ROSA THERAPEUTICS INC | 61225M102 | COM | 153,544 | $3,715,765 | dollars as filed | |
| ACADIA PHARMACEUTICALS INC | 004225108 | COM | 143,167 | $3,622,125 | dollars as filed | |
| SOLID BIOSCIENCES INC | 83422E204 | COMMON STOCK | 358,780 | $3,584,212 | dollars as filed | |
| PERSONALIS INC | 71535D106 | COMMON STOCK | 247,783 | $3,320,292 | dollars as filed | |
| CRESCENT BIOPHARMA INC | G2545C104 | COMMON STOCK | 182,382 | $3,282,876 | dollars as filed | |
| ARROWHEAD PHARMACEUTICALS IN | 04280A100 | COM | 39,198 | $3,195,029 | dollars as filed | |
| KODIAK SCIENCES INC | 50015M109 | COM | 75,872 | $2,955,973 | dollars as filed | |
| PHARVARIS NV | N69605108 | COMMON STOCK | 80,907 | $2,797,764 | dollars as filed | |
| MONOPAR THERAPEUTICS INC | 61023L207 | COMMON STOCK | 30,125 | $2,789,274 | dollars as filed | |
| RAPPORT THERAPEUTICS INC COM | 75383L102 | Stock | 66,582 | $2,774,472 | dollars as filed | |
| NEWAMSTERDAM PHARMA CO NV | N62509109 | COMMON STOCK | 77,589 | $2,629,491 | dollars as filed | |
| SIONNA THERAPEUTICS INC | 829401108 | COMMON STOCK | 59,426 | $2,614,150 | dollars as filed | |
| ARCUTIS BIOTHERAPEUTICS INC | 03969K108 | COM | 98,945 | $2,594,338 | dollars as filed | |
| C4 THERAPEUTICS INC | 12529R107 | COM STK | 523,648 | $2,445,436 | dollars as filed | |
| SPRUCE BIOSCIENCES INC | 85209E208 | COM NEW | 41,388 | $2,234,952 | dollars as filed | |
| CUE BIOPHARMA INC | 22978P205 | COM | 66,995 | $2,114,362 | dollars as filed | |
| STRUCTURE THERAPEUTICS INC COMP | 86366E106 | EQUITY | 38,178 | $2,049,013 | dollars as filed | |
| PROTAGONIST THERAPEUTICS | 74366E102 | COM | 16,303 | $1,998,422 | dollars as filed | |
| HELIX ACQUISITION CORP III | G4444S107 | USD CL A ORD SHS | 171,671 | $1,826,579 | dollars as filed | |
| BIODESIX INC COM | 09075X207 | Stock | 70,000 | $1,578,500 | dollars as filed | |
| TENAX THERAPEUTICS INC | 88032L605 | COM NEW | 96,273 | $1,400,772 | dollars as filed | |
| SAB BIOTHERAPEUTICS INC | 78397T202 | COMMON STOCK | 342,631 | $1,336,261 | dollars as filed | |
| CALCIMEDICA INC | 38942Q202 | COM NEW | 1,244,864 | $1,195,661 | dollars as filed | |
| LB PHARMACEUTICALS INC | 50180M108 | COMMON STOCK | 31,785 | $1,031,582 | dollars as filed | |
| CELLECTAR BIOSCIENCES INC | 15117F880 | COM NEW | 354,938 | $986,728 | dollars as filed | |
| PERSONALIS INC | 71535D106 | COMMON STOCK | 470,000 | $810,750 | dollars as filed | call |
| PROQR THERAPEUTICS NV | N71542109 | SHS EURO | 431,054 | $801,760 | dollars as filed | |
| BIOHAVEN LTD | G1110E107 | COM | 500,000 | $525,000 | dollars as filed | call |
| SPDR SER TR | 78464A870 | S&P BIOTECH | 250,000 | $400,000 | dollars as filed | put |
| ASTRAZENECA PLC ORD | G0593M107 | ADR | 25,000 | $180,000 | dollars as filed | call |
| SPDR SER TR | 78464A870 | S&P BIOTECH | 400,000 | $178,000 | dollars as filed | call |
| TANGO THERAPEUTICS INC | 87583X109 | COM | 100,000 | $175,000 | dollars as filed | call |
| REVOLUTION MEDICINES INC COM | 76155X100 | Stock | 30,000 | $127,500 | dollars as filed | put |
| ERASCA INC COM | 29479A108 | Stock | 200,000 | $90,000 | dollars as filed | put |
| ARK ETF TR | 00214Q302 | GENOMIC REV ETF | 100,000 | $75,000 | dollars as filed | put |
| ROIVANT SCIENCES LTD | G76279101 | SHS | 100,000 | $40,000 | dollars as filed | put |
| VISTAGEN THERAPEUTICS INC | 92840H400 | COM | 616,749 | $17,276 | dollars as filed | |
| Amgen Inc. | 031162100 | COM | 15,000 | $15,000 | dollars as filed | put |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001420506-26-001687 | this filing | 2026-08-14 | acceptance time not in the bulk data set |